HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability
about
sameAs
Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodiesAncient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3GIdentification and characterization of naturally occurring splice variants of SAMHD1The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3GFAM20: an evolutionarily conserved family of secreted proteins expressed in hematopoietic cellsT cell responses to human endogenous retroviruses in HIV-1 infectionRestriction of foamy viruses by APOBEC cytidine deaminasesMutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificitiesDifferential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion.Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylasesRole and mechanism of action of the APOBEC3 family of antiretroviral resistance factorsDifferential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replicationHIV-1 Vif and APOBEC3G: multiple roads to one goalA second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteinsTargeting APOBEC3A to the viral nucleoprotein complex confers antiviral activityA single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletionHow SAMHD1 changes our view of viral restrictionDifferential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypesStructural model for deoxycytidine deamination mechanisms of the HIV-1 inactivation enzyme APOBEC3GHIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factorsTurning up the volume on mutational pressure: is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3)HIV-1 Vif, APOBEC, and intrinsic immunityAPOBEC3G-UBA2 fusion as a potential strategy for stable expression of APOBEC3G and inhibition of HIV-1 replicationHuman cytidine deaminase APOBEC3H restricts HIV-1 replicationA single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivityThe HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradationStructural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assemblyInhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replicationIdentification of APOBEC3DE as another antiretroviral factor from the human APOBEC familyIdentification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidationPosttranslational acetylation of the human immunodeficiency virus type 1 integrase carboxyl-terminal domain is dispensable for viral replication7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3GEarly steps of retrovirus replicative cycleProduction of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cellsIntracellular immunity to HIV-1: newly defined retroviral battles inside infected cells.APOBEC3G targets human T-cell leukemia virus type 1.Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversificationDual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retrovirusesHIV Genome-Wide Protein Associations: a Review of 30 Years of Research
P2860
Q21090536-42F530E1-3DE2-4F45-90B4-B7454F83BAA2Q21146408-CD4945CF-5CD0-4F71-B353-1B6B6A9D9810Q21245040-2F63DAB5-5815-445B-A7A5-5E7EDAFE40C2Q21245195-47D0AB32-EC7C-48D3-BD07-AD83ACCF6688Q21266609-1E700801-4893-442E-8D9B-807250979019Q21559508-C148C0EF-9BF2-4D3F-BC47-87C34CBA5A9DQ24299944-4B1FDA13-7B99-4627-945C-FD1F6A9ED40AQ24521469-09CD9C13-A552-427B-8827-AAA96AAAD3FEQ24529150-7AF0DFF3-6D43-45BE-80F4-D3773D285275Q24530147-3C016665-E6FF-439D-8EF3-47692733A371Q24537623-82980215-CDA4-4097-AF14-6251A649600AQ24544264-2CAD0179-4D00-48F3-9DE3-010097B114D1Q24563503-230E4421-D5BC-4CB2-B5E3-0D316BFFE213Q24564072-FAF785F1-7B62-47D3-AFCD-6EA12B47756FQ24564187-C1417988-2E66-46A7-B5E8-4986A46486C9Q24565021-D5C93ED6-CCA4-4D01-8F23-A3F91206B657Q24568052-D05CE136-1A89-4133-96A6-2D047335744AQ24605899-8F15CF99-361D-43EC-BC23-6609437EB8E8Q24612992-B73C126A-A6DD-47CD-AC2E-05AF9950A67DQ24615413-358B721E-27CB-4200-AAE3-A64C22D0481EQ24619114-270E2FAB-924E-493E-9168-03B4E138A086Q24645606-678B3922-1458-41BD-AA77-4B38C2EF9700Q24647833-5CE83EB0-8258-4FEA-8910-26183AB2DD8AQ24651400-8B9A1BC3-332C-4541-9C05-69AB9839F7DDQ24653682-EBAA7891-925E-4D5F-8542-816CA3979C83Q24656551-FA752826-018A-4AE4-B2EC-A18EAABF93D4Q24657375-81D9CB5D-9DDB-40FA-A7A3-962193CA5D9CQ24658171-97C1F2C3-09A9-4252-9851-3AEE80E49691Q24669993-AB99DE96-EB75-4B45-86A5-C1D8DE6DB287Q24670173-9F684166-EC10-40F5-9458-651C64CCBCB9Q24672209-C8CC564C-6E86-4462-B0A2-8D1F284A6C1FQ24672416-EC7C6B78-BB09-4B5D-898E-03873596FC0FQ24681427-ED638238-F266-4DD5-BF36-B62D45F40D3FQ24792862-7C85C2B8-C21E-4027-A76B-1280B4AC2DADQ24796626-0A95DF0B-9E18-4CE4-B1BB-0A0B08CED3A9Q24805644-2802406B-976D-4401-A645-7C62B8F8082AQ24811566-16BB34F0-F69C-4180-8280-147DC2F11950Q24817186-E451DB22-8ECF-4C9F-8C12-7AFF8409E359Q25257798-5ACFB12D-110D-47D8-B357-3D7EBD285EF6Q26746070-5D3C0F5B-A1AF-4ED8-9729-D425BC67A6CF
P2860
HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
HIV-1 Vif blocks the antiviral ...... on and intracellular stability
@ast
HIV-1 Vif blocks the antiviral ...... on and intracellular stability
@en
HIV-1 Vif blocks the antiviral ...... on and intracellular stability
@nl
type
label
HIV-1 Vif blocks the antiviral ...... on and intracellular stability
@ast
HIV-1 Vif blocks the antiviral ...... on and intracellular stability
@en
HIV-1 Vif blocks the antiviral ...... on and intracellular stability
@nl
prefLabel
HIV-1 Vif blocks the antiviral ...... on and intracellular stability
@ast
HIV-1 Vif blocks the antiviral ...... on and intracellular stability
@en
HIV-1 Vif blocks the antiviral ...... on and intracellular stability
@nl
P2093
P3181
P1433
P1476
HIV-1 Vif blocks the antiviral ...... on and intracellular stability
@en
P2093
Carlos de Noronha
Kim Stopak
Warner C Greene
Wes Yonemoto
P304
P3181
P356
10.1016/S1097-2765(03)00353-8
P407
P577
2003-09-01T00:00:00Z